The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor
Open accessAbstract
Recent genetic experiments have suggested that tat transactivation of the human immunodeficiency virus type 1 (HIV-1) long terminal repeat requires functional upstream enhancer sequences--Sp1 sites, in particular. In these experiments, HeLa cell nuclear extracts were passed over affinity matrices containing chemically synthesized or bacterially expressed HIV-1 Tat. Assay of material that bound to and eluted from the Tat matrices revealed the presence of the Sp1 transcription factor. Other transcription factors (Oct and NF-kappa B) also bound to Tat matrices but with less efficiency--in parallel with the lower capacities of these binding motifs to confer Tat responsiveness on a basal HIV-1 promoter compared with Sp1 sites. Passage of nuclear extracts over matrices containing other neutral proteins, including bovine serum albumin, ovalbumin, and lysozyme, revealed no or reduced binding. Cross-linking experiments indicated that the purified Sp1 and Tat proteins can form multimeric complexes in the absence of other proteins. The region of Tat responsible for Sp1 binding was localized to a region encompassing residues 30 to 62. Immunoprecipitation experiments with HIV-1-infected T lymphocytes indicated coimmunoprecipitation of Tat and Sp1. These experiments extend previous genetic experiments and suggest a direct interaction between Tat and Sp1 during transactivation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dynan, W. S., & Tjian, R. (1983) · Cell · doi:10.1016/0092-8674(83)90210-6 · Cited by 1,445
Tat trans-activates the human immunodeficiency virus through a nascent RNA target
Berkhout, B., Silverman, R. H., & Jeang, K.-T. (1989) · Cell · doi:10.1016/0092-8674(89)90289-4 · Cited by 647
Self-citationFeinberg, M. B., Baltimore, D., & Frankel, A. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.4045 · Cited by 365
Cited by
Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro
Zhu, Y., Pe’ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M. B., & Price, D. H. (1997) · Genes & Development · doi:10.1101/gad.11.20.2622 · Cited by 696
CONTROL OF RNA INITIATION AND ELONGATION AT THE HIV-1 PROMOTER
Jones, K. A., & Peterlin, B. M. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.003441 · Cited by 618
Sp1 and the ‘hallmarks of cancer’
Beishline, K., & Azizkhan‐Clifford, J. (2015) · The FEBS Journal · doi:10.1111/febs.13148 · Cited by 524
Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions
Safe, S. (2001) · Vitamins & Hormones · doi:10.1016/s0083-6729(01)62006-5 · Cited by 418
HIV-1 Tat transcriptional activity is regulated by acetylation
Kiernan, R. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.6106 · Cited by 416
Metadata
- Authors
- Jeang, K. T., Chun, R., Lin, N. H., Gatignol, A., Glabe, C. G., & Fan, H.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1993-10
- Volume
- 67
- Issue
- 10
- Pages
- 6224-6233
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2095839679
- Cited by
- 217
- References
- 3
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. https://app.cochat.ai/papers/10.1128/jvi.67.10.6224-6233.1993
- The paper
- Jeang, K. T., Chun, R., Lin, N. H., Gatignol, A., Glabe, C. G., & Fan, H. (1993). In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. Journal of Virology. https://doi.org/10.1128/jvi.67.10.6224-6233.1993
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.